Olympus launches new colonoscopes designed to find more disease and improve treatment capabilities

Oklahoma Timed Event Closing TODAY - Bid Now
Cleansweep Live Auction Thursday Jan. 21 10AM EST - Pre-Bid Now

Olympus launches new colonoscopes designed to find more disease and improve treatment capabilities

Press releases may be edited for formatting or style | October 08, 2020 Endoscopy
CENTER VALLEY, Pa., Oct. 8, 2020 /PRNewswire/ -- Olympus announced today the 510(k) clearance and market availability of two colonoscopes, the PCF-H190T and the PCF-HQ190. The products provide an extension to the existing capabilities for physicians to diagnose and treat disorders of the gastrointestinal tract.

Olympus launches new colonoscopes which expand capability in minimally invasive procedures, including endoscopic submucosal dissection (ESD).
Olympus is a market leader in products to enable minimally invasive treatments such as Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection, https://medical.olympusamerica.com/procedure/emr-esd, procedures that can benefit from the use of state-of-the-art endoscopes. The benefits of HQ Dual Focus imaging and imaging modalities like Narrow Band Imaging (NBI), now available through a smaller diameter colonoscope, combine with capabilities such as retroflexion, to advance procedures and improve colonoscopy.

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

"With these GI endoscopes, Olympus continues to raise the bar on increased functionality, bringing the market a slimmer diameter endoscope, all while providing imaging excellence toward future innovations," said Kevin Mancini, Vice President for Endoscopy at Olympus America Inc. "We know our physician customers are excited about these advancements that will improve their access and visualization of the anatomy as well as a growing range of treatment modalities."

The new PCF-H190TL/I endoscope is a slim, short-bending scope that allows for tighter angulation without compromise to the passage of treatment accessories. Used with the EVIS EXERA III imaging platform, the PCF-H190TL/I is an HD device with a 510(k) claim for Narrow Band Imaging (NBI), which indicates NBI as a "high confidence" assist to an experienced endoscopist employing a validated polyp classification system such as the NBI International Colorectal Endoscopic (NICE) classification, aiding in distinguishing diminutive adenomatous polyps from non-adenomatous polyps during colonoscopy. Other features include:
Better retroflexion capability, a technique associated with improved adenoma detection rate (ADR).
Appropriate channel layout for passage of therapeutic accessories, such as for hemostasis or polypectomy.
Improved insertability to minimize patient discomfort.
The new PCF-HQ190L/I is equipped with Dual Focus technology for increased mucosal visualization. Used with the EVIS EXERA III imaging platform, the endoscope's NBI plus its near focus mode is associated with a greater than 90% agreement with pathological analysis in assigning post-polypectomy surveillance following colonoscopy. Other features include:

You Must Be Logged In To Post A Comment